Ananda Kumar Chettupalli

637 total citations
44 papers, 348 citations indexed

About

Ananda Kumar Chettupalli is a scholar working on Pharmaceutical Science, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Ananda Kumar Chettupalli has authored 44 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmaceutical Science, 7 papers in Molecular Biology and 6 papers in Analytical Chemistry. Recurrent topics in Ananda Kumar Chettupalli's work include Advanced Drug Delivery Systems (20 papers), Advancements in Transdermal Drug Delivery (12 papers) and Drug Solubulity and Delivery Systems (10 papers). Ananda Kumar Chettupalli is often cited by papers focused on Advanced Drug Delivery Systems (20 papers), Advancements in Transdermal Drug Delivery (12 papers) and Drug Solubulity and Delivery Systems (10 papers). Ananda Kumar Chettupalli collaborates with scholars based in India, Uganda and Saudi Arabia. Ananda Kumar Chettupalli's co-authors include Aziz Unnisa, Talib Hussain, Mohammed Asadullah Jahangir, Vasudha Bakshi, Abdul Muheem, Madhusudhan Alle, Jin‐Chul Kim, Garima Sharma, Fahad A. Al‐Abbasi and Imran Kazmi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Ananda Kumar Chettupalli

36 papers receiving 330 citations

Peers

Countries citing papers authored by Ananda Kumar Chettupalli

Since Specialization

Citations

This map shows the geographic impact of Ananda Kumar Chettupalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ananda Kumar Chettupalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ananda Kumar Chettupalli more than expected).

Fields of papers citing papers by Ananda Kumar Chettupalli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ananda Kumar Chettupalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ananda Kumar Chettupalli. The network helps show where Ananda Kumar Chettupalli may publish in the future.

Co-authorship network of co-authors of Ananda Kumar Chettupalli

This figure shows the co-authorship network connecting the top 25 collaborators of Ananda Kumar Chettupalli. A scholar is included among the top collaborators of Ananda Kumar Chettupalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ananda Kumar Chettupalli. Ananda Kumar Chettupalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential of exosomes for targeted therapy in neuroinfectious disease management: crossing the blood–brain barrier 2025 ·Tissue Barriers ·Sarad Pawar Naik Bukke, Shikha Yadav, (unknown), (unknown), (unknown), (unknown), Ananda Kumar Chettupalli, (unknown), (unknown), Zohre Eftekhari, (unknown), (unknown), Tadele Mekuriya Yadesa	0
2	Mucoadhesive lyophilized wafers loaded with nano-spanlastic felodipine formulation: development and characterization 2025 ·Scientific Reports ·Ananda Kumar Chettupalli, Sarad Pawar Naik Bukke, Malakapogu Ravindra Babu, (unknown), (unknown), (unknown)	0
3	Advances in cancer therapy: a critical review of β-cyclodextrins conjugated nanoparticle delivery systems as molecularly targeted therapies 2025 ·International Journal of Pharmaceutics ·(unknown), Sarad Pawar Naik Bukke, (unknown), Irfan Aamer Ansari, (unknown), (unknown), (unknown), Ananda Kumar Chettupalli, (unknown), Zohre Eftekhari, Hope Onohuean	5
4	Cutting-edge biomaterial in implantable devices: From biocompatibility to biointegration 2025 ·International Journal of Biological Macromolecules ·Ananda Kumar Chettupalli, Sarad Pawar Naik Bukke, Chetan Sharma	0
5	Post-operative infection treatment in cardiac surgery: current practices and future directions 2025 ·Perioperative Medicine ·(unknown), (unknown), Sarad Pawar Naik Bukke, Ananda Kumar Chettupalli, (unknown)	0
6	Design, development, and preclinical evaluation of pirfenidone-loaded nanostructured lipid carriers for pulmonary delivery 2025 ·Scientific Reports ·Ananda Kumar Chettupalli, (unknown), (unknown), (unknown), Mohammed Ghazwani, Umme Hani, (unknown), (unknown), M. Akiful Haque	2
7	Ritonavir loaded solid lipid nanoparticles for oral drug delivery and bioavailability enhancement 2025 ·Discover Applied Sciences ·Ananda Kumar Chettupalli, Sarad Pawar Naik Bukke, (unknown), Aziz Unnisa, (unknown), (unknown), Malakapogu Ravindra Babu, Bayapa Reddy Narapureddy, Hope Onohuean	6
8	Nanomedicine for the management of rheumatoid arthritis: current status and prospective therapeutic approaches 2025 ·Discover Medicine ·Neha Gupta, (unknown), Ananda Kumar Chettupalli, Sarad Pawar Naik Bukke, Narayana Goruntla	2
9	Recent advances in potential drug nanocarriers for CNS disorders: a review 2025 ·BioMedical Engineering OnLine ·(unknown), (unknown), Sarad Pawar Naik Bukke, (unknown), Ananda Kumar Chettupalli	0
10	Therapeutic promise of α-hederin in Alzheimer’s disease: Insights into inflammation, oxidative stress, and apoptosis modulation 2025 ·Biomedicine & Pharmacotherapy ·Ananda Kumar Chettupalli, (unknown), Sarad Pawar Naik Bukke, M. Singh, Chandan Mandal	1
11	Development and evaluation of empagliflozin-loaded solid lipid nanoparticles: Pharmacokinetics and pharmacodynamics for oral delivery 2025 ·SHILAP Revista de lepidopterología ·Ananda Kumar Chettupalli, Aziz Unnisa, (unknown), (unknown), (unknown), (unknown)	4
12	Development and optimization of dapagliflozin oral nano-bilosomes using response surface method: in vitro evaluation, in vivo evaluation 2024 ·Nanotheranostics ·Ananda Kumar Chettupalli, (unknown), (unknown), (unknown), (unknown), Harekrishna Roy, (unknown), V. S. Muralidharan, (unknown), M. Akiful Haque, (unknown), Talha Bin Emran	1
13	Transformative Approaches in Bone Pathology Treatment: The Efficacy of Alendronate-Infused Hydroxyapatite Microspheres 2024 ·Journal Of Biochemical Technology ·Sarad Pawar Naik Bukke, Saswati Mishra, (unknown), C.A. Reddy, Ananda Kumar Chettupalli, (unknown)	0
14	Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations 2023 ·Pharmaceuticals ·Aziz Unnisa, Ananda Kumar Chettupalli, (unknown), Walla Alelwani, Azzah M. Bannunah, Jameel Barnawi, (unknown), (unknown), (unknown), (unknown), Talib Hussain	16
15	Design of mesalamine loaded micro-particles: Preparation, in vitro and in-vivo characterization 2023 ·Materials Today Proceedings ·(unknown), (unknown), Ananda Kumar Chettupalli, (unknown), Mohammed Oday Ezzat	5
16	Design, formulation, in-vitro and in-vivo pharmacokinetic evaluation of Nicardipine- nanostructured lipid carrier for transdermal drug delivery system 2023 ·Materials Today Proceedings ·(unknown), Ananda Kumar Chettupalli, Vivek Chauhan, (unknown)	9
17	Response Surface Method for the Simultaneous Estimation of Atorvastatin and Olmesartan 2022 ·Trends in Sciences ·(unknown), Ananda Kumar Chettupalli, (unknown), (unknown), (unknown), Vinod Kumar Yata	7
18	Formulation and Evaluation of Poly Herbal Liqui-Solid Compact for its Anti-Inflammatory Effect 2021 ·Biointerface Research in Applied Chemistry ·Ananda Kumar Chettupalli, (unknown), (unknown), (unknown), (unknown), (unknown), Vinod Kumar Yata, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	7
19	Nano Phytomedicine Based Delivery System for CNS Disease 2020 ·Current Drug Metabolism ·Mohammed Asadullah Jahangir, Ananda Kumar Chettupalli, Abdul Muheem, Sadaf Jamal Gilani, Mohamad Taleuzzaman, Ameeduzzafar Zafar, Mohammed Jafar, Surajpal Verma, Md. Abul Barkat	26
20	Design, Formulation, In-Vitro and Ex-Vivo Evaluation of Atazanavir Loaded Cubosomal Gel 2020 ·Biointerface Research in Applied Chemistry ·Ananda Kumar Chettupalli, (unknown), (unknown), Vasudha Bakshi, Vinod Kumar Yata, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact